# Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion

> **NCT04140448** · — · UNKNOWN · sponsor: **Renmin Hospital of Wuhan University** · enrollment: 60 (estimated)

## Conditions studied

- Retinal Vein Occlusion
- Macular Edema

## Interventions

- **DRUG:** Ranibizumab 0.5 MG/0.05 ML Intraocular Solution [LUCENTIS]
- **DEVICE:** Ultra-wide Fluorescein Angiography

## Key facts

- **NCT ID:** NCT04140448
- **Lead sponsor:** Renmin Hospital of Wuhan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-09
- **Primary completion:** 2024-10-30
- **Final completion:** 2025-12-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04140448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04140448, "Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04140448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*